Component
Sodium salicylate
Sodium salicylate
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
Sodium salicylate prevented ALCAR-induced mGlu2 protein upregulation in FSL rats.
Experimental context and source evidence
- evidence_access
- Primary full text: relevant Results/Methods and figure descriptions reviewed; supplements only where explicitly stated.
- experimental_condition
- ALCAR alone 50 mg/kg · Sodium salicylate Condition belongs to the full experimental contrast; do not separate a joint intervention.
- experimental_condition
- ALCAR alone 100 mg/kg · Acetyl-L-carnitine Condition belongs to the full experimental contrast; do not separate a joint intervention.
- experimental_contrast
- {"intervention": "Salicylate plus ALCAR", "comparator": "ALCAR alone", "endpoint": "Sodium salicylate prevented ALCAR-induced mGlu2 protein upregulation in FSL rats.", "effect_direction": "decrease", "combination": "joint", "conditions": [{"entity_slug": "sodium-salicylate", "state": "50 mg/kg"}, {"entity_slug": "acetylcarnitine", "state": "100 mg/kg"}]} Explicit extracted experimental comparison; source-derived draft.
- experimental_model
- Salicylate 50 mg/kg intraperitoneal with ALCAR 100 mg/kg intraperitoneal for 21 days; Fig. 3D.
- interpretation_status
- Source-derived curation with stated access limits; ungraded, not independent replication.
- limitations
- Limited to the recorded preparation, model, exposure and endpoint. Does not establish a human dietary deficiency, clinical benefit or unique molecular mediation.
- nutrient_topic
- Acetyl-L-carnitine collection; exact intervention and molecular form govern interpretation. · Acetyl-L-carnitine
- plain_language
- Sodium salicylate prevented ALCAR-induced mGlu2 protein upregulation in FSL rats.
- primary_references
- L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors. | https://pubmed.ncbi.nlm.nih.gov/23382250/ | https://pmc.ncbi.nlm.nih.gov/articles/PMC3607061/ | https://doi.org/10.1073/pnas.1216100110
- source_locator
- Reviewed reference fsl-salicylate; The inhibitor was nonselective. This does not establish an ordinary aspirin-food interaction or prove acetyl-group provenance.
Acetyl-L-carnitine: detailed mechanisms of action (reviewed 6 October 2026) · lines 232–238
AI-assisted original review of primary studies and clearly identified official records. Exact primary access is stated; no independent replication is claimed. · supports · Salicylate 50 mg/kg intraperitoneal with ALCAR 100 mg/kg intraperitoneal for 21 days; Fig. 3D. · Recorded from source · Recorded from source
### fsl-salicylate Sodium salicylate prevented ALCAR-induced mGlu2 protein upregulation in FSL rats. The inhibitor was nonselective. This does not establish an ordinary aspirin-food interaction or prove acetyl-group provenance. Model and exposure: Salicylate 50 mg/kg intraperitoneal with ALCAR 100 mg/kg intraperitoneal for 21 days; Fig. 3D. Limitations: Limited to the recorded preparation, model, exposure and endpoint. Does not establish a human dietary deficiency, clinical benefit or unique molecular mediation. Reference: L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors. | 2013 | https://pubmed.ncbi.nlm.nih.gov/23382250/ | https://pmc.ncbi.nlm.nih.gov/articles/PMC3607061/ | https://doi.org/10.1073/pnas.1216100110 | Access: Primary full text: relevant Results/Methods and figure descriptions reviewed; supplements only where explicitly stated.
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.